MLR vs SCVL

MLR exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.08, indicating a fortress balance sheet. However, this financial stability is contrasted by a severe collapse in growth, with YoY earnings plummeting 67.10% and revenue declining 22.50%. While the stock trades near its Graham Number ($40.59), it is significantly above its growth-based intrinsic value ($13.86), suggesting the market is pricing in a recovery that is not yet evident in the data. The outlook remains neutral as the company's operational efficiency is currently offset by its exceptional solvency.

SCVL presents a classic value trap profile, characterized by a stable Piotroski F-Score of 4/9 and a current price ($18.89) that sits significantly below its Graham Number ($32.82) but above its growth-based intrinsic value ($13.30). While the company maintains a strong liquidity position with a current ratio of 3.76 and a sustainable dividend payout, it is battling severe fundamental decay. Revenue and earnings are both in negative territory, with YoY earnings growth plummeting by 37.9%, offsetting the appeal of its low P/E and P/B ratios.